Hidradenitis Suppurativa Huddle: Better Understand Pathophysiology for a Timely Diagnosis
CE Information
0.75 contact hoursCompletion Time
45 minutesAvailable Until
May 15, 2026Posted By
NP Events
Navigate
Overview
Specialties
Adult and FamilySubspecialties
Dermatology and Primary CareClinical Topics
Dermatologic Disease and Primary CareTarget Audience
This educational activity is intended for dermatology nurse practitioners and physician associates, as well as those practicing in primary care, who are engaged in the care of patients with hidradenitis suppurativa.
Program Learning Goal
The goal of this educational activity is to improve the knowledge and competence of nurse practitioner and physician associate learners in managing patients with hidradenitis suppurativa.
Learning Objectives
Upon completion of this activity, participants should be able to:
-
Utilize evidence-based guidelines to diagnose hidradenitis suppurativa in patients presenting with complex or atypical skin lesions
-
Evaluate clinical data of current and emerging therapeutic options for patients with hidradenitis suppurativa, considering patient-specific factors such as comorbidities and treatment history
-
Design personalized treatment plans that include patient preferences, lifestyle factors, and shared decision-making to optimize outcomes
-
Integrate patient perspectives and clinical evidence into collaborative care models that enhance communication and improve adherence to treatment plans
Speakers
Dermsurgery Associates – Kingwood
Houston, Texas
Professor & Founding Chair/Department of Dermatology
Zucker School of Medicine at Hofstra/Northwell
Professor/Center for Health Innovations & Outcomes Research
Feinstein Institutes for Medical Research
SVP/Dermatology Service Line
Northwell Health
Assistant Professor
Emory University PA Program
Atlanta, Georgia
CE Information
This activity offers 0.75 contact hours to attendees.
Accredited by ANCC.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and the Coalition of Skin Diseases (CSD). Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Disclosures
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Primary Author
Terry Faleye, MPAS, PA-C: speaker: AbbVie, Bristol Myers Squibb, Lilly, Regeneron/Sanofi, Sun Pharma, UCB; consultant: Incyte, Pfizer.
Amit Garg, MD: consultant/advisor/speaker: AbbVie, Almirall, Boehringer Ingelheim, Engitix, Immunitas, Incyte, Insmed, Novartis, Pfizer, Sonoma, Sun Pharma, UCB, Union Therapeutics, Zura Bio.
Martha L. Sikes, DMSc, RPh, PA-C: consultant/advisor/speaker: Ortho Dermatologics.
Brindley Brooks: other financial or material support: Incyte, Lilly, Moonlake, Novartis, Sanofi, UCB
Register For This Activity
OnDemand Activity Registration
Select this option to access the activity at no cost